Korean Drug Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	6,512	2,995	-4,917	11,809	9,042
Depreciation & Amortization	1,969	2,069	1,749	1,383	1,470
Loss (Gain) From Sale of Assets	-0.31	-3.56	3.68	-2.81	-1.13
Loss (Gain) From Sale of Investments	180.6	-72.9	-132.87	383.6	359.46
Other Operating Activities	2,616	-513.96	2,118	-801.33	1,384
Change in Accounts Receivable	-205.06	4,806	3,566	-1,390	-948.64
Change in Inventory	3,507	-1,605	-4,657	-971.78	-2,149
Change in Accounts Payable	672.64	-1,351	1,916	-3,208	550.5
Change in Other Net Operating Assets	-2,141	-1,455	-1,645	-1,288	-900.83
Operating Cash Flow	13,110	4,869	-1,999	5,913	8,806
Operating Cash Flow Growth	169.27%	-	-	-32.86%	-28.58%
Capital Expenditures	-457	-1,027	-5,814	-6,093	-1,146
Sale of Property, Plant & Equipment	0.32	7.46	1.12	5.86	4.5
Sale (Purchase) of Intangibles	-18.04	-15.71	-69.6	-384.22	157.73
Investment in Securities	-10,182	-9,830	18,159	894.66	-6,980
Other Investing Activities	125	-23.96	-0	175	-291
Investing Cash Flow	-10,532	-10,889	12,277	-5,401	-8,254
Long-Term Debt Repaid	-84.21	-88.34	-82.46	-76.55	-75.69
Total Debt Repaid	-84.21	-88.34	-82.46	-76.55	-75.69
Net Debt Issued (Repaid)	-84.21	-88.34	-82.46	-76.55	-75.69
Issuance of Common Stock	24.61	133.7	18.31	3.61	24.01
Repurchase of Common Stock	-	-	-	-	-1,103
Dividends Paid	-1,730	-1,618	-1,941	-1,833	-1,634
Other Financing Activities	0	-	-2.9	0	0
Financing Cash Flow	-1,790	-1,573	-2,008	-1,906	-2,789
Foreign Exchange Rate Adjustments	-5.41	6.89	-7.09	-20.35	10.95
Miscellaneous Cash Flow Adjustments	0	0	0	0	-
Net Cash Flow	782.47	-7,586	8,263	-1,415	-2,227
Free Cash Flow	12,653	3,842	-7,812	-180.15	7,660
Free Cash Flow Growth	229.34%	-	-	-	-33.92%
Free Cash Flow Margin	20.24%	5.26%	-9.60%	-0.22%	10.29%
Free Cash Flow Per Share	-	356.01	-724.50	-16.71	701.12
Cash Interest Paid	3.88	4.24	3.02	2.1	1.53
Cash Income Tax Paid	812.44	3,792	12,140	3,383	2,274
Levered Free Cash Flow	11,770	3,630	2,092	-2,709	6,243
Unlevered Free Cash Flow	11,772	3,632	2,094	-2,707	6,244
Change in Working Capital	1,833	395.21	-819.69	-6,858	-3,448

Source: S&P Global Market Intelligence. Standard template. Financial Sources.